Annovis Open Label starting end of March

[Ctime]

At the end of year Annovis Investor Meeting, Maria announced open label for Parkinson's starting at the end of March. The open label for Parkinson's will be for patients who have already participated in the Annovis Trial.

They are planning a new study with new enrollees in Parkinson's starting in summer 2025. They are currently working to understand why Buntanetap worked in some sub-groups. They need to raise money for the new Parkinsons study but confirm financing for the open label and a new Alzheimer study.

[jocelyng]

do you have a link to more information? Thanks.

[ProudParkie2017 in reply to jocelyng]

They recommend anyone on the previous study who would like to go back on should email them at: [e-mail]

The open label extension will be 30 mg as opposed to the 10 or 20 mgs that were the doses on the trial. Anyone who was on the Trial is allowed to go back on the open extension. That March date will be for anyone who was on the Alzheimer’s or the Parkinson’s trial for the open label extension. They will be recruiting new participants for a blind study starting in January for Alzheimer’s and summer for Parkinson’s if they can raise enough money.

They have FDA approval for the Alzheimer’s trial and the open label extensions for both.

One of the interesting things she talked about was that about 15 sites in Florida who did not follow proper protocol for either. They recruited people who did not have either Alzheimer’s or Parkinson’s.

I will say they are very responsive to emails when you send an email question or asking for information about the trials.

[jocelyng in reply to ProudParkie2017]

Thanks. I don’t recall anything about the prior study, so I’ll email them to get details.

[Ctime in reply to jocelyng]

The recording is here. app.getresponse.com/click.h...

[park_bear in reply to jocelyng]

Yesterday's investor presentation here: youtu.be/NA3kCUZZIpI(Not working as expected?)

[jocelyng in reply to park_bear]

Thanks!

[Triever7]

I’m an investor too. I was not in the earlier trial. Disappointed I can't join the open label one. The drug definitely sounds promising.

[jocelyng in reply to Triever7]

why can’t you join?

[Triever7 in reply to jocelyng]

Only people who participated in their previous trials can join.

[jocelyng in reply to Triever7]

Oh. I misunderstood the earlier post. That eliminates me, too.

[ProudParkie2017 in reply to jocelyng]

You may be eligible for the new study they will start recruiting for in the summer!!

[jocelyng in reply to ProudParkie2017]

Ok. I guess I’ll email them to make sure they have my contact info.

[MBAnderson]

Thank you Ctime.

[Ctime]

Just a note that I had to call my clinic yesterday about some billing issues and they confirmed that they had heard from Annovis and were restarting the Alzheimer in January and had be informed about the open label in march but were waiting for final details in the new year